Compugen Ltd (CGEN) Reports In-Line Q3 Loss of 11c/Share

Compugen Ltd (NASDAQ: CGEN) reported Q3 EPS of ($0.11), in-line with the analyst estimate of ($0.11). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $1.9 million.

For earnings history and earnings-related data on Compugen Ltd (CGEN) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Celcuity (CELC) Reiterates at Market Outperform by Citizens Ahead of Upcoming Launch
• reAlpha Tech Corp. (AIRE) Misses Q2 EPS by 7c